Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis

FEMS Immunology and Medical Microbiology

Volumn 55, Issue 2, 2009, Pages 258-270

  Coler, Rhea N ^a   Bhatia, Ajay ^a   Maisonneuve, Jean Francois ^b,c   Probst, Peter ^b,d   Barth, Brenda ^b   Ovendale, Pamela ^b   Fang, Hang ^b   Alderson, Mark ^b,c   Lobet, Yves ^e   Cohen, Joe ^e   Mettens, Pascal ^e   Reed, Steven G ^a  

^a INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^b GLAXOSMITHKLINE   (United States)

^c PATH   (United States)

^d VLST Corporation   (United States)

^e GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Adjuvant; Chlamydia; Vaccine

Indexed keywords

AS 01B; CHLAMYDIA TRACHOMATIS VACCINE; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; LIPOSOME; MEDROXYPROGESTERONE ACETATE; PHOSPHORYL LIPID A; QS 21; RECOMBINANT ANTIGEN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ORGANELLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONFERENCE PAPER; CONTROLLED STUDY; DENDRITIC CELL; ELEMENTARY BODY; FEMALE; GENITAL TRACT INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOPROPHYLAXIS; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINATION; VACCINE PRODUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COLONY COUNT, MICROBIAL; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECOMBINANT PROTEINS; VACCINES, SYNTHETIC;

EID: 60049100267     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2008.00527.x     Document Type: Conference Paper

References (47)

1. Alderson MR, Bement T, Day CH et al 2000) Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells. J Exp Med 191 : 551 560.
2. Barr EL, Ouburg S, Igietseme JU et al 2005) Host inflammatory response and development of complications of Chlamydia trachomatis genital infection in CCR5-deficient mice and subfertile women with the CCR5delta32 gene deletion. J Microbiol Immunol Infect 38 : 244 254.
3. Batteiger BE, Rank RG, Bavoil PM Soderberg LS (1993) Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis. J Gen Microbiol 139 : 2965 2972.
4. Behets FM, Miller WC Cohen MS (2001) Syndromic treatment of gonococcal and chlamydial infections in women seeking primary care for the genital discharge syndrome: decision-making. B World Health Organ 79 : 1070 1075.
5. Berthet FX, Rasmussen PB, Rosenkrands I, Andersen P Gicquel B (1998) A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 144 : 3195 3203.
6. Brunham RC Rey-Ladino J (2005) Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 5 : 149 161.
7. Cain TK Rank RG (1995) Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun 63 : 1784 1789.
8. Cotter TW, Ramsey KH, Miranpuri GS, Poulsen CE Byrne GI (1997) Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect Immun 65 : 2145 2152.
9. de la Maza LM Peterson EM (2002) Vaccines for Chlamydia trachomatis infections. Curr Opin Investig D 3 : 980 986.
10. Gervassi A, Alderson MR, Suchland R, Maisonneuve JF, Grabstein KH Probst P (2004) Differential regulation of inflammatory cytokine secretion by human dendritic cells upon Chlamydia trachomatis infection. Infect Immun 72 : 7231 7239.
11. Grayston JT Wang SP (1978) The potential for vaccine against infection of the genital tract with Chlamydia trachomatis. Sex Transm Dis 5 : 73 77.
12. Igietseme JU Murdin A (2000) Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes. Infect Immun 68 : 6798 6806.
13. Igietseme JU Ward ME (2004) Chlamydia update. Expert Rev Vaccines 3 : 639 642.
14. Igietseme JU, Black CM Caldwell HD (2002) Chlamydia vaccines: strategies and status. BioDrugs 16 : 19 35.
15. Johansson M, Schon K, Ward M Lycke N (1997) Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is this true for humans? Scand J Immunol 46 : 546 552.
16. Mardh PA (2004) Tubal factor infertility, with special regard to chlamydial salpingitis. Curr Opin Infect Dis 17 : 49 52.
17. Meijer A, Morre SA, van den Brule AJ, Savelkoul PH Ossewaarde JM (1999) Genomic relatedness of Chlamydia isolates determined by amplified fragment length polymorphism analysis. J Bacteriol 181 : 4469 4475.
18. Mettens P, Dubois PM, Demoitie MA et al 2008) Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen. Vaccine 26 : 1072 1082.
19. Morrison RP Caldwell HD (2002) Immunity to murine chlamydial genital infection. Infect Immun 70 : 2741 2751.
20. Morrison RP, Feilzer K Tumas DB (1995) Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect Immun 63 : 4661 4668.
21. Morrison SG Morrison RP (2001) Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells. Infect Immun 69 : 2643 2649.
22. Morrison SG Morrison RP (2005) The protective effect of antibody in immunity to murine chlamydial genital tract reinfection is independent of immunoglobulin A. Infect Immun 73 : 6183 6186.
23. Paavonen J Eggert-Kruse W (1999) Chlamydia trachomatis: impact on human reproduction. Hum Reprod Update 5 : 433 447.
24. Pal S, Davis HL, Peterson EM de la Maza LM (2002) Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge. Infect Immun 70 : 4812 4817.
25. Pear WS, Nolan GP, Scott ML Baltimore D (1993) Production of high-titer helper-free retroviruses by transient transfection. P Natl Acad Sci USA 90 : 8392 8396.
26. Perry LL, Feilzer K Caldwell HD (1997) Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J Immun 158 : 3344 3352.
27. Pichyangkul S, Gettayacamin M, Miller RS et al 2004) Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alum. Vaccine 22 : 3831 3840.
28. Probst P, Stromberg E, Ghalib HW, Mozel M, Badaro R, Reed SG Webb JR (2001) Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning. J Immunol 166 : 498 505.
29. Rank RG, Batteiger BE Soderberg LS (1990) Immunization against chlamydial genital infection in guinea pigs with UV-inactivated and viable chlamydiae administered by different routes. Infect Immun 58 : 2599 2605.
30. Ridgway GL (1997) Treatment of chlamydial genital infection. J Antimicrob Chemoth 40 : 311 314.
31. Sanderson S, Campbell DJ Shastri N (1995) Identification of a CD4+ T cell-stimulating antigen of pathogenic bacteria by expression cloning. J Exp Med 182 : 1751 1757.
32. Skeiky YA, Ovendale PJ, Jen S et al 2000) T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection [In Process Citation]. J Immun 165 : 7140 7149.
33. Skeiky YA, Alderson MR, Ovendale PJ et al 2004) Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. J Immun 172 : 7618 7628.
34. Starnbach MN, Bevan MJ Lampe MF (1994) Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. J Immunol 153 : 5183 5189.
35. Stephens RS (2003) The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 11 : 44 51.
36. Su H, Parnell M Caldwell HD (1995) Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection. Vaccine 13 : 1023 1032.
37. Su H, Feilzer K, Caldwell HD Morrison RP (1997) Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect Immun 65 : 1993 1999.
38. Su H, Messer R, Whitmire W, Fischer E, Portis JC Caldwell HD (1998) Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J Exp Med 188 : 809 818.
39. Tan TW, Herring AJ, Anderson IE Jones GE (1990) Protection of sheep against Chlamydia psittaci infection with a subcellular vaccine containing the major outer membrane protein. Infect Immun 58 : 3101 3108.
40. Taylor HR, Whittum-Hudson J, Schachter J, Caldwell HD Prendergast RA (1988) Oral immunization with chlamydial major outer membrane protein (MOMP). Invest Ophth Vis Sci 29 : 1847 1853.
41. Tuffrey M, Falder P, Gale J Taylor-Robinson D (1986) Salpingitis in mice induced by human strains of Chlamydia trachomatis. Brit J Exp Pathol 67 : 605 616.
42. Tuffrey M, Alexander F Taylor-Robinson D (1990) Severity of salpingitis in mice after primary and repeated inoculation with a human strain of Chlamydia trachomatis. J Exp Pathol 71 : 403 410.
43. Tuffrey M, Alexander F, Conlan W, Woods C Ward M (1992) Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlamydia trachomatis by prior immunization with recombinant serovar L1 major outer-membrane protein. J Gen Microbiol 138 : 1707 1715.
44. van Valkengoed IG, Morre SA, van den Brule AJ, Meijer CJ, Bouter LM Boeke AJ (2004) Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes - implications for cost-effectiveness analyses. Int J Epidemiol 33 : 416 425.
45. Ward ME (1992) Chlamydial vaccines - future trends. J Infect 25 (suppl 1) : 11 26.
46. WHO (1990) Sexually transmitted infections increasing - 250 million new infections annually. WHO Feature 152 : 1 6.
47. WHO (2001) Global Prevalence and Incidence of Selected Curable Sexually Transmitted Diseases: Overview and Estimates, pp. 1 34. World Health Organization DHA, Geneva, Switzerland.